Clinical Trials Browser

Withdrawn × Interventional × Stroke × Clear all

Focal Cortical Dysplasia, Brain Neoplasms, Encephalitis, Epilepsy, Gliosis, Sturge-Weber Syndrome, Tuberous Sclerosis, Stroke, Hemimegalencephaly, Polymicrogyria

NCT04361552 2020-06-18

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Phase 3 Withdrawn

Genitourinary

COVID-19, Coronary Artery Disease, Diabetes Mellitus, Kidney Failure, Chronic, Neoplasms, Stroke, Pulmonary Disease, Chronic Obstructive

Clinical Trials

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)